HRT Financial’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-73,794
Closed -$8.55M 3005
2023
Q3
$8.55M Buy
+73,794
New +$10.2M 0.09% 162
2023
Q2
Sell
-74,107
Closed -$13M 3201
2023
Q1
$13M Buy
74,107
+35,670
+93% +$6M 0.16% 102
2022
Q4
$5.21M Buy
38,437
+29,025
+308% +$3.81M 0.07% 257
2022
Q3
$1.16M Sell
9,412
-27,301
-74% -$3.65M 0.01% 826
2022
Q2
$5.15M Buy
36,713
+3,009
+9% +$421K 0.06% 238
2022
Q1
$5.06M Sell
33,704
-9,748
-22% -$1.56M 0.04% 289
2021
Q4
$8.97M Buy
43,452
+27,816
+178% +$5.12M 0.05% 177
2021
Q3
$2.19M Buy
+15,636
New +$2.35M 0.01% 680
2021
Q1
Sell
-2,544
Closed -$323K 3106
2020
Q4
$323K Sell
2,544
-9,293
-79% -$1.05M 0.01% 1245
2020
Q3
$1.16M Buy
+11,837
New +$1.19M 0.03% 443
2020
Q1
Sell
-3,094
Closed -$358K 1292
2019
Q4
$358K Sell
3,094
-4,612
-60% -$506K 0.02% 669
2019
Q3
$858K Buy
+7,706
New +$834K 0.04% 425

Other funds holding SLAB

HRT Financial's SLAB Position: Q4 2023 in Review

HRT Financial sold out of Silicon Laboratories (SLAB) in Q4 2023, closing a stake of 73,794 shares — an estimated $8.55M sold.

HRT Financial first reported a position in SLAB in Q3 2019 and held it in 12 quarters. The position peaked at $13M in Q1 2023. 295 funds tracked by Wall St. Rank hold SLAB as of Q4 2023.

  • HRT Financial reported no remaining Silicon Laboratories position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 73,794 Silicon Laboratories shares in Q4 2023, an estimated $8.55M.
  • HRT Financial first reported a position in Silicon Laboratories in Q3 2019 and held it in 12 quarters.
  • HRT Financial's Silicon Laboratories position peaked at $13M in Q1 2023.
  • 295 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.